Table 3 Incidence of new-onset diabetes and clinical events during the 3-year follow-up
Variable | Pitavastatin 1 mg (n = 251) | Pitavastatin 4 mg (n = 251) | p-value |
|---|---|---|---|
New-onset diabetes | 14 (5.6%) | 9 (3.6%) | 0.39 |
Baseline ~ 1 year | 1 (0.4%) | 0 (0.0%) | 0.99 |
> 1 year | 13 (5.2%) | 9 (3.6%) | 0.39 |
All cause death | 9 (3.6%) | 8 (3.2%) | 0.99 |
Cardiac death | 3 (1.2%) | 1 (0.4%) | 0.62 |
Non-fatal myocardial infarction | 14 (5.6%) | 8 (3.2%) | 0.28 |
Ischemic stroke | 5 (2.0%) | 2 (0.8%) | 0.45 |
Target lesion revascularization | 12 (4.8%) | 9 (3.6%) | 0.66 |
Target vessel revascularization | 18 (7.2%) | 13 (5.2%) | 0.46 |
Non-target lesion/vessel revascularization | 7 (2.8%) | 15 (6.0%) | 0.13 |